Haffkine Biopharma to produce 22.8 crore doses per annum of Covaxin under technology transfer arrangement with Bharat Biotech, With the aim of vaccinating the entire eligible population at the earliest, domestic vaccine production is being steadily ramped up in the country with help from the Centre.
As part of this initiative, three public enterprises are being supported by the Department of Biotechnology under Atmanirbhar Bharat 3.0 Mission Covid Suraksha. These enterprises are the
1. Haffkine Biopharmaceutical Corporation Ltd, Mumbai,
2.Indian Immunologicals Ltd, Hyderabad and
3.Bharat Immunologicals & Biologicals Ltd, Bulandshahar, UP.
Read more at: https://pib.gov.in/PressReleasePage.aspx?PRID=1723608
- 3 Jun 2021